{
 "awd_id": "9161004",
 "agcy_id": "NSF",
 "tran_type": "Grant",
 "awd_istr_txt": "Standard Grant",
 "awd_titl_txt": "Improvements in Aerobic Bioreactor Cell Capacity through FacFacilitated Oxygen Transport Agents",
 "cfda_num": "47.084",
 "org_code": "15030000",
 "po_phone": null,
 "po_email": "",
 "po_sign_block_name": "Ritchie B. Coryell",
 "awd_eff_date": "1992-01-01",
 "awd_exp_date": "1992-09-30",
 "tot_intn_awd_amt": 49993.0,
 "awd_amount": 49993.0,
 "awd_min_amd_letter_date": "1991-12-20",
 "awd_max_amd_letter_date": "1991-12-20",
 "awd_abstract_narration": "Aquanautics Corporation synthesizes and characterizes                           oxygen binding complexes.  These compounds are intended                         for commercial applications ranging from oxygen removal                         (for example, beverage oxygen filters) to low power oxygen                      production (for example, the \"artificial gill\").  This                          project is to exploit some of these compounds as agents to                      facilitate oxygen flux to Saccharomyces cerevisae (Baker's                      yeast) and mammalian cells.                                                                                                                                     The objective of this proposal is twofold.  One is to show                      that protozoan and metazoan cultures are compatible with                        transition metal binding compounds. The other is to                             demonstrate that such an additive will enable the                               maintenance of higher cell densities or higher cell                             metabolism rates.  If this research is successful, the                          cell genetic products can be produced more economically.",
 "awd_arra_amount": 0.0,
 "dir_abbr": "TIP",
 "org_dir_long_name": "Directorate for Technology, Innovation, and Partnerships",
 "div_abbr": "TI",
 "org_div_long_name": "Translational Impacts",
 "awd_agcy_code": "4900",
 "fund_agcy_code": "4900",
 "pi": [
  {
   "pi_role": "Principal Investigator",
   "pi_first_name": "John",
   "pi_last_name": "Kerr",
   "pi_mid_init": "",
   "pi_sufx_name": "",
   "pi_full_name": "John Kerr",
   "pi_email_addr": "",
   "nsf_id": "000381673",
   "pi_start_date": "1992-01-01",
   "pi_end_date": null
  }
 ],
 "inst": {
  "inst_name": "Aquanautics Corporation",
  "inst_street_address": "980 Atlantic Avenue Suite 101",
  "inst_street_address_2": "",
  "inst_city_name": "Alameda",
  "inst_state_code": "CA",
  "inst_state_name": "California",
  "inst_phone_num": "4155214331",
  "inst_zip_code": "945011018",
  "inst_country_name": "United States",
  "cong_dist_code": "12",
  "st_cong_dist_code": "CA12",
  "org_lgl_bus_name": null,
  "org_prnt_uei_num": null,
  "org_uei_num": null
 },
 "perf_inst": {
  "perf_inst_name": "DATA NOT AVAILABLE",
  "perf_str_addr": "",
  "perf_city_name": "",
  "perf_st_code": "",
  "perf_st_name": "RI REQUIRED",
  "perf_zip_code": "",
  "perf_ctry_code": "",
  "perf_cong_dist": "",
  "perf_st_cong_dist": "",
  "perf_ctry_name": "",
  "perf_ctry_flag": "0"
 },
 "pgm_ele": [
  {
   "pgm_ele_code": "537100",
   "pgm_ele_name": "SBIR Phase I"
  }
 ],
 "pgm_ref": [
  {
   "pgm_ref_code": "1491",
   "pgm_ref_txt": "BIOTECH, BIOCHEM & BIOMASS ENG"
  },
  {
   "pgm_ref_code": "1497",
   "pgm_ref_txt": "ARCHITECTURE & MECHAN SYSTEMS"
  },
  {
   "pgm_ref_code": "5371",
   "pgm_ref_txt": "SMALL BUSINESS PHASE I"
  }
 ],
 "app_fund": [
  {
   "app_code": "",
   "app_name": "",
   "app_symb_id": "",
   "fund_code": "",
   "fund_name": "",
   "fund_symb_id": ""
  }
 ],
 "oblg_fy": [
  {
   "fund_oblg_fiscal_yr": 1992,
   "fund_oblg_amt": 49993.0
  }
 ],
 "por": null
}